Clinical trial Recruiting at 1 site Observational Ages 18 and up

Compare the HUAWEI D2 wristwatch blood pressure readings to international BP standard requirements

Official title: An Observational Cross-Sectional Blind Comparison to Evaluate the Level of Agreement Between AAMI/ESH/ISO Universal Standard Requirements and the HUAWEI D2 Watch-Type Wrist Blood Pressure Monitor

Run by Northumbria University · NCT07297277 · Data updated 2026-11-12

This project will test whether the HUAWEI D2 wrist blood pressure watch gives accurate readings that match international BP standards in adults.

More Blood Pressure Monitoring trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment85 (estimated)
SponsorNorthumbria University
Academic / other
Locations1 site (Newcastle upon Tyne)
StatusRecruiting
StartedJuly 15, 2025
Main results expectedOctober 2027
Study endsOctober 2027
Registry record updatedDecember 30, 2025
Trial IDNCT07297277 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged over 18 without arrhythmias, peripheral arterial disease, known heart disease, pregnancy, or secondary hypertension who can attend the testing site and provide informed consent.

Probably not a fit

People with cardiac arrhythmias, peripheral arterial disease, known heart disease, pregnancy, or secondary hypertension are unlikely to benefit because the device is not validated for those conditions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational validation compares blood pressure measurements from the HUAWEI D2 watch with the AAMI/ESH/ISO universal standard requirements using standard validation procedures. The device has passed prior testing in China, and investigators will collect measurements from adult participants at a single site in the UK to assess agreement across a different population. Adults over 18 who can give informed consent and do not have arrhythmias, peripheral arterial disease, known heart disease, pregnancy, or secondary hypertension are eligible. Data will be analysed to determine whether the watch meets the predefined accuracy criteria from the international protocol.

Why it matters

Potential benefit: If successful, the watch could offer a convenient, validated option for at-home blood pressure monitoring across more populations.

How similar studies have gone: Similar AAMI/ESH/ISO validation protocols have been used before and the HUAWEI D2 passed testing in China, though wrist oscillometric devices have shown variable accuracy across different populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \>18 years
* Written informed consent provided

Exclusion Criteria:

* Cardiac Arrythmias
* Peripheral Arterial Disease
* Known Heart Disease
* Pregnancy
* Diagnosis of Secondary Hypertension

Where it's running

  • Northumbria University
    Newcastle upon Tyne, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.